259 related articles for article (PubMed ID: 25008880)
1. [Therapeutic effects of different doses of botulinum toxin A injection on tiptoe deformation in children with cerebral palsy].
Niu GH; Zhang XL; Zhu DN; Cai ZJ; Li SS; Zhang W
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):720-4. PubMed ID: 25008880
[TBL] [Abstract][Full Text] [Related]
2. [Effects of botulinum toxin guided by electric stimulation on spasticity in ankle plantar flexor of children with cerebral palsy: a randomized trial].
Xu KS; Yan TB; Mai JN
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):913-7. PubMed ID: 17254459
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin-A with and without rehabilitation for the treatment of spastic cerebral palsy.
Jianjun L; Shurong J; Weihong W; Yan Z; Fanyong Z; Nanling L
J Int Med Res; 2013 Jun; 41(3):636-41. PubMed ID: 23696596
[TBL] [Abstract][Full Text] [Related]
4. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
5. [Effect of botulinum toxin A injection in the treatment of gastrocnemius spasticity in children aged 9-36 months with cerebral palsy: a prospective study].
Zhu DN; Wang MM; Wang J; Zhang W; Li HZ; Yang P; Xiong HC; Niu GH; Li SS; Zhao YX
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Feb; 18(2):123-9. PubMed ID: 26903058
[TBL] [Abstract][Full Text] [Related]
6. The relief effect of botulinum toxin-A for spastic iliopsoas of cerebral palsy on children.
Liu JJ; Ji SR; Wu WH; Zhang Y; Zeng FY; Li NL
Eur Rev Med Pharmacol Sci; 2014; 18(21):3223-8. PubMed ID: 25487932
[TBL] [Abstract][Full Text] [Related]
7. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
[TBL] [Abstract][Full Text] [Related]
8. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.
Love SC; Valentine JP; Blair EM; Price CJ; Cole JH; Chauvel PJ
Eur J Neurol; 2001 Nov; 8 Suppl 5():50-8. PubMed ID: 11851734
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.
Wang YJ; Gao BQ
World J Pediatr; 2013 Nov; 9(4):342-5. PubMed ID: 24235067
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of therapeutic response to physiotherapy with or without botulinum toxin injection using diffusion tensor tractography and clinical scores in term diplegic cerebral palsy children.
Chaturvedi SK; Rai Y; Chourasia A; Goel P; Paliwal VK; Garg RK; Rathore RK; Pandey CM; Gupta RK
Brain Dev; 2013 Aug; 35(7):647-53. PubMed ID: 23165172
[TBL] [Abstract][Full Text] [Related]
12. Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.
Unlu E; Cevikol A; Bal B; Gonen E; Celik O; Kose G
Clinics (Sao Paulo); 2010 Jun; 65(6):613-9. PubMed ID: 20613938
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites.
Sätilä H; Pietikäinen T; Iisalo T; Lehtonen-Räty P; Salo M; Haataja R; Koivikko M; Autti-Rämö I
Am J Phys Med Rehabil; 2008 May; 87(5):386-94. PubMed ID: 18427220
[TBL] [Abstract][Full Text] [Related]
14. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
15. Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy.
Colovic H; Dimitrijevic L; Stankovic I; Nikolic D; Radovic-Janosevic D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):41-7. PubMed ID: 22580859
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
Kwon JY; Hwang JH; Kim JS
Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Botulinum Toxin Injections on Gross Motor Function for Lower Limb Spasticity in Children with Cerebral Palsy.
Choi JY; Kim SK; Park ES
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31717282
[TBL] [Abstract][Full Text] [Related]
19. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
Lee JH; Sung IY; Yoo JY; Park EH; Park SR
J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
[TBL] [Abstract][Full Text] [Related]
20. Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.
Sätilä HK; Pietikäinen T; Lehtonen-Räty P; Koivikko M; Autti-Rämö I
Neuropediatrics; 2006 Dec; 37(6):344-9. PubMed ID: 17357036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
